Related Experiment Video
Updated: May 20, 2026

High Content Screening in Neurodegenerative Diseases
Published on: January 6, 2012
When access is an issue: exploring barriers to predictive testing for Huntington disease in British Columbia, Canada
Alice K Hawkins1, Susan Creighton, Michael R Hayden
1Department of Medical Genetics, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, BC, Canada. alicehaw@exchange.ubc.ca
Insights
Predictive testing for Huntington disease (HD) is often inaccessible due to distance and inflexible scheduling, preventing at-risk individuals from accessing crucial genetic services and support.
Area of Science:
- Genetics
- Public Health
- Healthcare Accessibility
Background:
- Predictive testing (PT) for Huntington disease (HD) involves multiple in-person appointments.
- Current PT accessibility issues may prevent at-risk individuals from receiving potential benefits.
Purpose of the Study:
- To investigate accessibility barriers to PT for Huntington disease (HD).
- To explore potential solutions for improving PT service delivery.
Main Methods:
- An interview study was conducted with individuals at risk for HD in British Columbia, Canada.
- Qualitative data were gathered to understand patient perspectives on PT access.
Main Results:
- Accessibility barriers to PT include structural issues (distance, travel time, costs) and process inflexibility (emotional/psychological access).
- These barriers deter individuals from obtaining essential support, information, and counseling.
- Inflexible PT processes and geographical distance limit access to genetic services.
Conclusions:
- Creative and adaptable solutions are needed to personalize the delivery of genetic services.
- Improving access to PT is crucial for enhancing quality of life and preventing healthcare inequities.
- Rethinking service delivery can address access barriers and ensure equitable healthcare for individuals at risk of HD.
Abstract:
Predictive testing (PT) for Huntington disease (HD) requires several in-person appointments. This requirement may be a barrier to testing so that at risk individuals do not realize the potential benefits of PT. To understand the obstacles to PT in terms of the accessibility of services, as well as exploring mechanisms by which this issue may be addressed, we conducted an interview study of individuals at risk for HD throughout British Columbia, Canada. Results reveal that the accessibility of PT can be a barrier for two major reasons: distance and the inflexibility of the testing process. Distance is a structural barrier, and relates to the time and travel required to access PT, the financial and other opportunity costs associated with taking time away from work and family to attend appointments and the stress of navigating urban centers. The inflexibility of the testing process barrier relates to the emotional and psychological accessibility of PT. The results of the interview study reveal that there are access barriers to PT that deter individuals from receiving the support, information and counseling they require. What makes accessibility of PT services important is not just that it may result in differences in quality of life and care, but because these differences may be addressed with creative and adaptable solutions in the delivery of genetic services. The study findings underscore the need for us to rethink and personalize the way we deliver such services to improve access issues to prevent inequities in the health care system.
Related Concept Videos
Huntington Disease l: Introduction
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Pharmacogenomics: Identification of New Drug Targets
